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Abstract 
Exposure Therapy: Stimulus Intensity as a Factor in Treatment Preference 
Matthew C. Arias 
Currently, a host of treatments are available for treating anxiety disorders, including specific 
phobia. Treatment of specific phobia includes pharmacological, psychosocial, and combined 
approaches. Exposure therapy, however, is considered the leading psychological treatment for 
specific phobia, and has shown to be effective. Exposure therapy challenges held beliefs about 
feared stimuli/situations and attempts to integrate new learning about the feared object/situation. 
Despite exposure being effective to treat specific phobia, it is associated with low adherence and 
high dropout rates. There is a need to examine, therefore, ways to improve patient adherence for 
exposure. A way to examine this issue is to assess patient preferences for currently available 
treatments for specific phobia, and to examine directly the various methods for delivering 
exposure (e.g., stimuli intensity presentation). Furthermore, it is important to assess individuals’ 
perception of efficacy on various methods of delivering exposure stimuli (e.g., low intensity 
versus high intensity). Also, it is essential to examine individual willingness to engage in 
different presentation of stimuli intensity. Participants (N = 1,065) were assessed for dental care-
related fear and anxiety, and 279 of those individuals with high levels of fear/anxiety were 
included in the analyses regarding treatment preferences. Participants rated their preference for 
types of treatments (e.g., exposure, flooding, systematic desensitization) and were asked to rank 
order-based on personal preference. Then participants watched two video examples of exposure 
(i.e., low intensity and high intensity) and asked to rate their preference for the two methods to 
deliver exposure stimuli. After, participants rank ordered several approaches for delivering 
exposure stimuli by personal preference. Finally, participants were given a free choice to watch 
either a black screen (e.g., avoidance), low intensity exposure video, or high intensity exposure 
video over three trials. Results indicated that participants rated relaxation as the most preferred 
type of treatment for dental phobia. In regard to exposure stimuli, participants rated the low 
intensity exposure stimuli with greater preference (e.g., more efficacious and more willing to 
engage in the treatment) than the high intensity exposure stimuli. A majority of participants 
watched the low intensity (39.6%) and the avoidance video (32.8%) two or more times over the 
three trials demonstrating a behavioral preference for video content. A Latent Class Analysis 
suggested distinct groups (i.e., Low to Avoidant, and Avoidant) based on the patterns of video 
choice over the three trials. Findings of this study highlight differences in patient preferences for 
specific phobia treatment, which ultimately can impact oral health care services and training. 
Utilizing low intensity exposure stimuli may be a promising way to get patient buy-in and ease 
into higher intensity stimuli and possible improve treatment outcomes.  
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Exposure Therapy: Stimulus Intensity as a Factor in Treatment Preference 
A myriad of treatments are available for treating anxiety disorders, including specific 
phobia. Psychotherapy for the treatment of specific phobia ranges from developing alternative, 
positive thoughts about the feared stimulus/situation, to uncovering unconscious processes that 
contribute to the experience of anxiety, to experiencing situations in which fearful responding is 
challenged with new learning. Despite the availability of various treatments for phobia, less than 
50% of affected people utilize any available treatment for this disorder (Wang et al., 2005). 
Exposure therapy, a specific Cognitive Behavior Therapy (CBT) method, has been shown to be 
efficacious and is considered a leading treatment for specific phobia; however, it often has low 
utilization rates (Choy, Fyer, & Lipsit, 2007; Daflos & Whittal, 2012; Wolitzky-Taylor, 
Horowitz, Powers, & Telch, 2008). Moreover, dropout is common with exposure, and has rates 
as high as 45% for specific phobia treatment (Choy et al., 2007). Exposure treatment may be 
perceived and experienced as particularly challenging difficult by patients because the goal is to 
change fear responding by purposely contacting fear-evoking stimuli and situations.  
Given the issues of low utilization and high dropout, there is a need to examine what 
patients prefer and will tolerate in the treatment of phobia involving exposure. One salient factor 
related to patient preference in exposure treatment is the level of stimulus intensity. For example, 
actually flying on an airplane would be a high intensity step for someone with a phobia of flying. 
In this case, a contrasting low intensity exposure would be sitting in an airport, without a planned 
airline trip. Successfully boarding and flying on a plane would be an end goal for someone with a 
phobia of flying, and would be an ideal exposure situation, but few patients would prefer or 
tolerate that step early in treatment. There are one-session exposure treatments for specific 
phobias (Davis, Ollendick, & Ost, 2012), but they are daunting for many patients.  
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Patient preference is believed to relate to patient adherence, defined as “the ability of an 
individual to conform to a treatment regimen…as outlined by a health care provider” (American 
Psychological Association, 2015, p. 21). Adherence in relation to psychotherapy at least involves 
a patient attending psychotherapy sessions, active engagement in those treatment sessions, and 
completing out-of-session homework assignments. The importance of this issue is that even the 
most effective treatments must be accepted and utilized by patients for positive outcomes to 
occur (McNeil, 2011).  
Specific Phobia 
Specific phobia is one of the anxiety disorders as defined by the Diagnostic and 
Statistical Manual of Mental Disorders, 5th edition (DSM-5), and is the experience of fear related 
to a particular stimulus/situation, worry related to encountering the feared object/situation, and 
hindrance of daily functioning (American Psychiatric Association, 2013). The DSM-5 has five 
category types of specific phobia: Animal, Natural Environment, Situational, 
Blood/Injection/Injury, and Other. Prevalence rate for specific phobia is 8.7%, and over 20% of 
those with a specific phobia are considered in the severe category (Kessler et al., 2005). This 
study involved individuals with high levels of dental care-related fear/anxiety as an exemplar for 
specific phobia (McNeil & Randall, 2014) due to high prevalence rates (e.g., up to 20%) in the 
USA and similar avoidant behaviors as observed in other phobias (Smith & Heaton, 2003). 
Psychosocial Treatments for Specific Phobia 
Cognitive behavior therapy (CBT). CBT is a common and effective approach for 
treating phobia and other disorders, and incorporates behavioral (e.g., extinction) and cognitive 
(e.g., thought restructuring) principles. CBT can include many different techniques to help treat 
specific phobia, such systematic desensitization, exposure, or flooding (O’Donohue & Fisher, 
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2009). Other CBT approaches include thought restructuring (i.e., disputing negative thoughts 
about a feared object/situation by examining the evidence) and arousal control (e.g., activating 
the parasympathetic nervous system through relaxation, diaphragmatic breathing, and/or 
progressive muscle relaxation when encountering feared stimuli).  
Exposure therapy. Several forms of exposure therapy exist, such as in vivo (e.g., real-
life), in vitro (e.g., role-play), and in imago (e.g., imaginal); see McNeil and Kyle (2017).  
Additionally, exposure itself is the basis for systematic desensitization, flooding, and implosive 
therapy, although “exposure” has become known as its own method (McNeil & Kyle, 2017).  
Systematic desensitization was the first rendition of exposure therapy, developed by Wolpe 
(1958), used in combination with relaxation training or medication, and based on classical 
conditioning principles. Specifically, systematic desensitization was first based on the theory of 
counterconditioning (e.g., maladaptive associations being replaced with adaptive ones by pairing 
the fear with something positive; Masters, Burish, Hollon, & Rimm, 1987). Since two 
incompatible responses cannot exist simultaneously, systematic desensitization typically utilizes 
relaxation training as an incompatible response to anxiety/fear (Masters et al., 1987). Once the 
patient is trained in relaxation, then a fear hierarchy is constructed, which is a list and/or 
description (typically consisting of 10 – 15 items) of fear/anxiety-evoking situations (Masters et 
al., 1987). Typically, the hierarchy increases in intensity, first with early “easy” steps followed 
by higher intensity ones over the series, culminating in the goal response (e.g., having a dental 
treatment visit for someone with dental phobia; McNeil & Kyle, 2017). The patient works 
through the fear hierarchy with the therapist by starting at the first step and practicing relaxation 
during imaginal exposure, and then only moves onto the next step when the fear response is no 
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longer experienced, or is sufficiently reduced, during the current step (Masters et al., 1987). 
Overall, the process is designed to limit the amount of fear experienced by the patient.  
A common alternative theory for the effectiveness of systematic desensitization is 
extinction, which is a foundational principle in exposure therapy. The intended objective of 
exposure therapy is to generate behavior change (e.g., interacting with a feared object/situation), 
and to decrease, and ultimately stop, negative reactions to that feared object or situation, also 
known as extinction (Pavlov, 1927). When a neutral stimulus (e.g., sight of an anesthetic needle) 
is repeatedly paired with an unconditioned stimulus (e.g., pain from the needle prick), it will 
cause an unconditioned response (e.g., increased arousal; McNeil & Kyle, 2017). Also, the 
neutral stimulus will become a conditioned stimulus and produce a conditioned response (e.g., 
seeing an anestetic needle causes increased arousal; McNeil & Kyle, 2017). With repeated 
presentations of the conditioned stimulus in the absence of the unconditioned stimulus, 
habituation will occur and the conditioned stimulus will not produce a conditioned response 
(e.g., leading to “extinction” or no longer expereincing a fear response; Herry et al., 2010). 
Craske et al. (2008) offers a more refined explanation for effectiveness of exposure therapy 
based in emotional processing theory, which incorporates the concept of habituation by Groves 
and Thompson (1970) and Rachman's (1980) theory of corrective learning. Through emotional 
processing, two conditions must be met for a decrease in fear. First, the fear-related stimulus is 
presented and activates the fear structure. Second, the new information presented must be 
incompatible with information in the fear structure (Foa & Kozak, 1986). Based on the two 
purported requirements for successful behavior change, higher intensity stimuli may activate the 
fear structure more effectively than low intensity stimuli, which in turn presents greater 
opportunity for acquiring incompatible information. Of note, a low intensity stimulus may not be 
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sufficiently evocative enough to invalidate previously held beliefs about a fear item/situation, 
which would then make the exposure not as effective.  
A major goal of exposure therapy is to induce learning about the feared stimulus or 
situation that is incompatible with the patient’s negative expectations (Craske, Treanor, Conway, 
Zbozinek, & Vervliet, 2014). Inhibitory learning models suggest that the original learned 
information about a feared stimulus or situation is not erased from memory, but that exposure 
produces additional, new learning about the stimulus/situation (Craske et al., 2014). It is 
important for the newly learned information to be incompatible to what is expected when coming 
in contact with the stimulus/situation (Craske et al., 2014).  
Lang (1971) proposed that a fear structure is the mental representation of a stimulus (e.g., 
needle), response to the stimulus (e.g., increased arousal), and related meaning (e.g., I am in a 
dental office and need a root canal to relieve pain). In order to produce corrective learning, the 
fear structure must be activated and then new, incompatible information related to the fear 
structure must be presented (Foa & Kozak, 1986). In other words, the existing fear structure is 
challenged by developing new memories of the stimulus or situation. Exposure therapy allows 
for experiences of corrective learning, and can produce habituation (Craske et al., 2008). Lang’s 
(1971) conceptualization is consistent with the most current and accepted view of mechanisms 
involved in exposure therapy and reason for decreased response (i.e., extinction) is through the 
process of habituation and inhibitory learning vis a vis conditioned fear stimuli/situations (Myers 
& Davis, 2007).  
Expectancy violation and increased arousal are important features in effective exposure 
therapy (Craske et al., 2014; Culver, Stoyanova, & Craske, 2012). In order to develop new 
learning about the feared object/situation, the exposures should violate the held expectations 
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(e.g., frequency or intensity) about the feared object/situation (Craske et al., 2014). In addition to 
expectancy violation, increased arousal during the exposure task is associated with longer lasting 
treatment gains (Culver et al., 2012). Evidence suggest that increased arousal may optimize 
learning during extinction of a fear response (Cain, Blouin, & Barad, 2004).  A posited 
mechanism is that increased adrenergic activity improves the consolidation of memories (Culver 
et al., 2012).  
Arousal and expectancy violation are important mechanisms in exposure treatment, but 
will only lead to effective treatment and positive outcomes if the patient is willing to engage in 
such a treatment. Consequently, it may behoove clinicians to start with low intensity exposure at 
the start of treatment to generate willingness to engage in treatment, and then move to higher 
intensity exposure that more fully violates patient expectations and generates high arousal for 
greater therapeutic change. The approach of starting with low intensity and increasing the level 
of intensity with a hierarchy is a common method in delivering exposure. Regardless of the 
mechanisms involved, patient adherence and level of stimulus intensity are crucial for 
therapeutic gains.  
Pharmacological Treatments for Specific Phobia  
Medications can be an effective approach to managing anxiety, at least on a temporary 
and time-limited basis (Farach et al., 2012). Little evidence, however, exist for medications to be 
a stand-alone treatment for specific phobia; nevertheless, medication is often used as an acute 
treatment for phobia (Bandelow et al., 2012; Choy et al., 2007). Medications used in anxiety 
treatment can include benzodiazepines (i.e., increases GABA levels), selective serotonin 
reuptake inhibitors (i.e., increases serotonin level), and/or beta-blockers (i.e., decreases 
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norepinephrine levels; Smith, Robinson, & Segal, 2017); various forms of sedation also are 
utilized for phobia treatment (Choy et al., 2007). 
Benzodiazepines. Wilhelm and Roth (1997) found that a benzodiazepine (i.e., 
alprazolam) decreased anxiety during a flight for patients with flight phobia, but a week later 
during another flight without the medication, the patients’ anxiety (e.g., self-report and 
physiological reactivity) was higher than a placebo group. Furthermore, a benzodiazepine (i.e., 
midazolam) successfully decreased self-reported anxiety immediately before a dental surgery 
compared to a control group, and had the same effect as a one-session psychological treatment 
(e.g., relaxation; Jöhren, Jackowski, Gängler, Sartory, & Thom, 2000). Benzodiazepines may be 
used on a prn (i.e., when necessary) basis and short-term basis for certain phobias (e.g., flight or 
dental phobia; Bandelow et al., 2012). 
Selective Serotonin Reuptake Inhibitors (SSRI). The efficacy, tolerance, and safety of 
utilizing SSRIs in the treatment of anxiety disorders has shown to be good, and often are 
considered the first-line in pharmacological treatment of fear (Bandelow et al., 2012). Several 
SSRIs (e.g., escitalopram, paroxetine, fluoxetine, fluvoxamine) have demonstrated effectiveness 
in treating a range of specific phobias (e.g., storms, flying, enclosed spaces, heights, dental, 
animals; Alamy, Wei Zhang, Varia, Davidson, & Connor, 2008; Balon, 1999; Benjamin, Ben-
Zion, Karbofsky, & Dannon, 2000). Despite that SSRIs appear to effectively treat phobia 
disorder, a meta-analysis by Roest et al. (2015) suggested that the effectiveness may be 
overestimated.  
Beta-blockers. Another pharmacological approach is the use of beta-blockers, which 
target the physical symptoms often associated with acute anxiety (e.g., shaking hands, sweating, 
and increased heart rate) and are prescribed “off-label” (i.e., without FDA approval; Dooley, 
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2015). Yaghoobi, Mahmoodiyeh, Khezri, Hashemian, and Fard (2015) found the beta-blocker 
propranolol effectively decreased self-reported anxiety prior to a medical surgery. Propranolol 
also has been extensively assessed in treating performance anxiety, and has been shown to be 
effective (e.g., “stage fright;” Dooley, 2015). Furthermore, Liu, Milgrom, and Fiset (1991) found 
that a beta-blocker (i.e., oxprenolol) resulted in lower self-reported anxiety during a needle 
injection in a sample of patients with high physiological arousal during a dental visit, and less 
pain experienced during the dental visit compared to a control group.  
Sedatives. Lastly, general anesthesia and nitrous oxide have also been assessed in 
patients with dental phobia as a way to complete dental care-related visits (Choy et al., 2007). 
Specifically, Berggren and Linde (1984), comparing general anesthesia and behavioral therapy, 
found that in a sample of people who experienced high levels of dental anxiety and avoidance, 
general anesthesia was effective in completing two tooth restoration visits and lowering self-
reported anxiety. Completion of the dental treatment and likelihood to attend future dental visits, 
however, was better for the behavioral therapy group (i.e., 92% completion rate and 78% return 
rate) than the anesthesia group (i.e., 69% completion rate and 53% return rate; Berggren & 
Linde, 1984). Willumsen, Vassend, and Hoffart (2001) found that nitrous oxide was as beneficial 
in lowering dental anxiety as a standard 10-week cognitive/behavioral or cognitive therapy 
treatment. Overall, the evidence suggests that medications have the potential to effectively 
decrease anxiety experienced in the moment. Armfield and Heaton (2013) posit that individuals 
with high levels of anxiety and acute treatment needs may benefit from the use of sedatives as a 
form of treatment. However, general anesthesia should be a last resort option for highly anxious 
individuals because it only targets the need for dental treatment rather than the anxiety associated 
with oral healthcare (Armfield & Heaton, 2013).  
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Patient Adherence for Specific Phobia Treatments 
Regardless of the form of treatment, effectiveness of virtually all treatments are based on 
patient adherence, which is defined as the ability to comply with the treatment as a whole, 
including taking medications as prescribed, showing up for and actively participating in 
treatment sessions, and doing agreed-upon homework outside of sessions. The available 
evidence shows that treatment adherence is variable, and for some individuals, may be poor 
(Taylor, Abramowitz, & McKay, 2012). Wheaton et al. (2016) found that for a sample of 
patients with obsessive-compulsive disorder (OCD), homework-based exposure tasks were not 
conducted by the patients approximately 25% time, which impacted overall treatment. 
Furthermore, Simpson et al. (2011) found that adherence to between-session exposure treatment 
(i.e., daily exposure tasks that increase in intensity day-to-day) for OCD significantly predicted 
decreased symptomology at the end of treatment. In particular, patients with high adherence rates 
early in treatment (i.e., lower intensity stimuli) resulted in greater therapeutic gains than those 
with high levels of adherence later in treatment (i.e., higher intensity stimuli; Simpson et al., 
2011). Furthermore, patients’ with high adherence to between-session “homework” activities 
(e.g., exposure), when receiving CBT for anxiety disorders, reported decreased anxiety compared 
to those with low adherence rates (Glenn et al., 2013).  
The most significant issue in regard to treatment is patients who drop out prematurely, or 
never truly get involved from the beginning, because of negative perceptions or reactions about 
the treatment (Taylor et al., 2012). For example, some patients may have thoughts that certain 
treatments are too intense (e.g., flooding), that the treatment may not benefit them, or that they 
may wish to not use medications. A common problem in CBT is high dropout rates, which have 
been shown to range from 9-21% for generalized anxiety treatment and as high as 45% for dental 
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phobia treatment (Choy et al., 2007; Taylor et al., 2012). Some possible reasons for dropout rates 
associated with CBT are low motivation for change, patient preference for a different treatment 
than what is offered, and/or patient perception that the treatment is not credible (Taylor et al., 
2012). It is important to examine ways to increase adherence with exposure treatment because it 
is considered the leading treatment for specific phobia (Wolitzky-Taylor et al., 2008). A possible 
factor impacting treatment adherence and decreased dropout is patient preference regarding 
specific aspects of treatment (e.g., stimulus intensity for exposure). Swift, Callahan, and Vollmer 
(2011) found that clients receiving their preferred treatment were approximately 50% less likely 
to drop out of treatment. It is important, therefore, to assess patient preferences for treatment 
with the goal to improve overall adherence rates.  
Patient Preferences for Type of Treatment  
It has been shown that treatment preference is related to treatment outcomes, and patients 
may indicate a preference for type of treatment, which may impact overall outcomes (Swift & 
Callahan, 2009; Swift et al., 2011). Patient preferences for treatment may lead therapists in 
deciding the actual components used in treatment (e.g., with or without exposure). Kazantzis, 
Ford, Paganini, Dattilio, and Farchione (2017) found that when a patient states a reluctance to 
receive exposure treatment, a clinician is less likely to include exposure as part of treatment (e.g., 
CBT without exposure). A meta-analysis by Adamson et al. (2008) found that when patients’ 
preference for musculoskeletal pain treatment matches the intervention received, outcomes are 
improved. McPherson, Britton, and Wennberg (1997) stated that patient preference and treatment 
effect are intertwined, but often not examined in randomized control trials. Treatment preference 
is based on knowledge or assumed knowledge on the part of the patient, and how the clinician 
describes/presents the treatment. Patients may use a myriad of sources to acquire information 
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about treatments, including the internet, which may be accurate or inaccurate depending on the 
source of information. Ipser, Dewing, and Stein (2007) state that the quality of information on 
anxiety treatment found on the internet, including specific phobia, was moderate to poor, and the 
users may be presented with misinformation on how to treat anxiety disorders. Furthermore, 
general knowledge about exposure among lay people may be misguided, such that they may 
view exposure therapy as unhelpful, unacceptable, and unethical to use for treatment of anxiety 
disorders (Richard & Gloster, 2007).  
Medication versus psychotherapeutic treatment. Preference for pharmacological over 
psychological treatment may differ across disorders, but overwhelmingly for anxiety disorders, 
the preferred treatment among patients is psychotherapy (Deacon & Abramowitz, 2005; McHugh 
& Whitton, 2013). A meta-analysis indicated that 75% of patients with anxiety disorders prefer 
psychological treatments over pharmacological ones (McHugh & Whitton, 2013). In a study 
examining treatment preference for older adults diagnosed with an anxiety disorder, 76% 
reported a preference for psychological treatment over a pharmacological approach (i.e., 13%) or 
a combined approach (i.e., 11%; Mohlman, 2012). It has been shown that pharmacological 
treatment and CBT are equally rated by patients diagnosed with an anxiety disorder as 
“favorable,” but CBT is rated as more acceptable and effective than pharmacological treatment 
(Deacon & Abramowitz, 2005). Of 103 outpatients diagnosed with an anxiety disorder, there 
were 74.3%  who reported CBT as a first-choice treatment, compared to 25.7% indicating a first-
choice preference for medications (Deacon & Abramowitz, 2005). Additionally, 13% of the 
patients indicated a preference to not use medications for anxiety treatment, while 100% of the 
patients were favorable about CBT as a treatment method, likely including some who would 
prefer its use in conjunction with medications (Deacon & Abramowitz, 2005). Wheaton, 
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Carpenter, Kalanthroff, Foa, and Simpson (2016), however, found that 32% of OCD patients 
indicated a preference for medication (e.g., risperidone) over exposure treatment. Furthermore, 
Jöhren et al. (2000) found that some participants were unwilling to receive psychotherapy and 
requested pharmacological treatment with dental phobia; however, the authors did not specify 
the percentage of the sample unwilling to receive psychotherapy. Finally, a meta-analysis on 
preference for treatment of posttraumatic stress disorder (PTSD) demonstrated a strong 
preference for exposure therapy as opposed to a pharmacological approach.  
The differences in percentages of patients preferring a certain treatment over another 
indicate that therapy should be individually tailored to increase adherence and utilization rates. 
Treatment should depend, in part, on the preference of the patient. Some patients, for example, 
may indicate a preference for not receiving medications and vice versa. If the treatment 
prescribed is different than requested, treatment adherence may be low.  
CBT versus other psychotherapeutic treatments. Literature examining patient 
preferences for various forms of psychological treatment (e.g., psychodynamic versus CBT) is 
sparse. Bragesjö, Clinton, and Sandell (2004), however, found that the general public rates CBT 
as more credible, helpful, and preferred compared to psychodynamic psychotherapy. Similarly, 
Frövenholt, Bragesjö, Clinton, and Sandell (2007) found that the general public rated an 
overwhelming preference for CBT over psychodynamic or cognitive therapy; however, patient 
samples were more likely to prefer psychodynamic and cognitive therapy over CBT (Frövenholt 
et al., 2007). In a study examining treatment preference for older adults diagnosed with anxiety 
problems, 29% reported a preference for CBT, which was greater than supportive therapy (i.e., 
27%), psychodynamic therapy (i.e., 7%), and acceptance-based therapy (i.e., 4%; Mohlman, 
2012). Furthermore, Johansson, Nyblom, Carlbring, Cuijpers, and Andersson (2013) found that 
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when given a choice between internet-based psychodynamic psychotherapy (IPDT) and internet-
based CBT (ICBT) for treatment of major depressive disorder, patients were two times as likely 
to choose the ICBT over the IPDT.  
Increasing Willingness to Engage in Exposure Treatment  
 Given that CBT, which includes exposure therapy, is the gold standard and preferred by 
some patients and particularly those with an anxiety disorder, it is important to examine ways to 
improve willingness to engage in the treatment. Treatment preferences have been seen to impact 
overall engagement and utilization of treatment, and it is important to examine preferences 
regarding factors that are exposure treatment-specific. For example, level of stimuli intensity is 
particularly important in exposure therapy, as higher intensity stimuli typically are associated 
with the ultimate goal of exposure treatment. If the intensity of a stimulus is too great, however, 
then adherence might be low. On the other hand, if the intensity of the stimulus is too weak, then 
little to no therapeutic change may occur. Systematic desensitization paved the way for the 
development and fine tuning of exposure therapy. Wolpe (1958) made the assumption that 
patients should experience little to no anxiety during the process of exposure to allow 
counterconditioning to occur. Current understandings of exposure therapy do not support that 
theory, but Wolpe may have uncovered something important in how exposure should be 
presented to patients (e.g., starting with low intensity) to increase treatment adherence. For 
example, a recent study found good adherence rates (i.e., watching an exposure video more than 
one time a day on average) of participants with high levels of dental care-related fear in a two-
week exposure treatment, which could be attributed to the low intensity of the videos watched 
(Arias & McNeil, 2019). Moreover, individuals appear to prefer a CBT- and/or exposure-based 
treatment for PTSD, but rate exposure-based treatments as highly uncomfortable (Tarrier, 
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Liversidge, & Gregg, 2006). Thus, easing into exposure stimuli (i.e., low intensity first) may 
decrease thoughts about experiencing discomfort within treatment.  
It has been shown that utilizing a “random” approach to presentation of graded exposure 
stimuli (e.g., varying levels of difficulty) is as effective in treating phobia with exposure in 
comparison to proceeding sequentially from the lowest to the highest (Lang & Craske, 2000; 
Rowe & Craske, 1998). Masters et al. (1987) suggest that stimuli presentation should start at the 
lowest and gradually increase for highest levels of patient adherence, but going in a descending 
order or only completing the highest three exposure steps also demonstrates effective fear 
reduction. However, experiencing the higher levels of stimuli intensity, particularly early in 
treatment, may lead to increased patient dropout because of the greater distress (Masters et al., 
1987). Thus, it may not be necessary in terms of efficacy to present the exposure stimuli in 
ascending order, but that approach may be crucial for some patients to stay in treatment. For 
example, if the patient prefers to limit the distress and anxiety experienced, then using a low 
intensity stimulus to begin with may improve treatment adherence and decrease dropout. 
Although many studies have assessed patient preference and beliefs about exposure therapy 
compared to medication or other psychotherapy treatments (Jaeger, Echiverri, Zoellner, Post, & 
Feeny, 2009), few studies have directly assessed patient preference for various formats (e.g., low 
intensity versus high intensity content) of delivering exposure therapy. Thus, it is important to 
assess patient preferences for stimulus intensity and presentational approach in order to increase 
overall treatment adherence.  
Statement of the Problem 
 A common issue in the delivery of psychotherapy is adherence at levels that inhibit 
therapeutic gains, especially when exposure therapy is the proposed treatment (Simpson et al., 
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2011; Taylor et al., 2012; Wheaton et al., 2016). Nevertheless, previous research has 
demonstrated that exposure therapy can effectively be used to treat phobias and other anxiety 
disorders (Hellström & Öst, 1995; Michelson, Mavissakalian, Marchione, Dancu, & Greenwald, 
1986; Schneider, Mataix-Cols, Marks, & Bachofen, 2005). There are various options for 
treatment of specific phobia (e.g., exposure, medications, supportive therapy, muscle relaxation), 
and each of these may be affected by the patient’s decision to not pursue treatment and to 
continue avoidance. Patients may be hesitant to receive exposure treatment because the goal is to 
challenge fears by coming in contact with the feared stimulus/situation. These avoidant 
behaviors with many specific phobias are possible because of their circumscribed effects on 
quality of life. Little is known about preferences for treatment among individuals in the general 
population who have specific phobia. The intensity of the presented exposure stimuli is one 
factor that may influence adherence to treatment. It is important to assess how to balance factors 
that might increase patient adherence (e.g., using low intensity stimuli) versus features that may 
make a treatment effective (e.g., using high intensity stimuli) in order to evoke therapeutic 
change. Low-intensity stimuli might increase patient buy-in and also lead to increased adherence 
when a part of an escalating hierarchy of exposure stimuli. Patient preference for treatment of 
phobia, thus, is an important factor to consider when developing and utilizing evidenced-based 
treatments. Generally, it is important to assess patients’ willingness to engage in exposure 
treatment.  
Hypotheses 
Research Question 1: Preference for Treatment  
What percent of the sample from the general population in the USA who report high 
levels of dental fear/anxiety prefer which types of specific phobia treatments?  
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Hypothesis 1. A majority of participants will report higher levels of preference for 
systematic desensitization over exposure, flooding, arousal control alone, medications, or 
combinations of these various methods. 
Research Question 2: Preference for Stimuli Order  
What percent of the sample from the general population in the USA who report high 
levels of dental fear/anxiety prefer a certain order of stimulus intensity presentation for exposure 
therapy? 
Hypothesis 2. A majority of participants will prefer a gradual accelerating approach (low 
to high intensity) relative to a high-intensity exposure, low-intensity exposure, gradual 
decelerating approach (high to low intensity), or a random approach.  
Research Question 3: Perceived Effectiveness and Willingness to Engage in Treatment  
How do participants who report high levels of dental fear/anxiety rate the effectiveness of 
exposure therapy and their willingness to engage in exposure differ for low and a high intensity 
stimuli presentation? 
Hypothesis 3a. A majority of participants will choose to view low intensity anxiety-
related video stimuli rather than high intensity anxiety-related video stimuli, as a measure of 
behavioral preference for low intensity exposure-related material.  
Hypothesis 3b. A majority of participants will rate the high intensity exposure as more 
effective in treating their phobia than the low intensity exposure.  
Hypothesis 3c. A majority of participants will report greater willingness to engage in the 
low intensity exposure compared to the high intensity exposure.  
Method 
Participants  
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 Power was determined by the planned analysis of hypothesis 1, utilizing a repeated 
measure Analysis of Variance (ANOVA) with one group rating preference on four different 
treatment options. According to a power analysis program, G*Power 3 (Faul, Erdfelder, Lang, & 
Buchner, 2007), to achieve a power of φ = .95 at a small effect size of .10 with four within 
measurements, a sample size of 216 was suggested. In order to allow for incomplete responses, 
dropout, and excluding participants based on the exclusion criteria, a total of 1,065 participants 
were screened in order to recruit 300 participants.  
Data from participants were collected via “Amazon Mechanical Turk (M-Turk),” which 
is a web-based tool used for data collection across the world (www.mturk.com). M-Turk workers 
are compensated for completing “Human Intelligence Tasks” (e.g., completing the proposed 
study). MTurk is regarded as an inexpensive and effective method of obtaining data from diverse 
samples, which include greater diversity than college student participant pools (Buhrmester, 
Kwang, & Gosling, 2011). Behavioral and psychological research often utilizes MTurk as a 
means to collect data, and MTurk-based participants have been shown to have comparable 
responses to participants who are part of in-person experiments (Casler, Bickel, & Hackett, 2013; 
Crano, Brewer, & Lac, 2014; Mason & Suri, 2012). 
Inclusion for participation included self-reported fluency in the English language, being 
18 years of age or older, indicating residency in the USA, reporting significant dental care-
related fear/anxiety (e.g., 4+ out of 5 on a single item dental fear question), and completing the 
screening phase of the study. Exclusion criteria were self-report of current treatment for phobia 
or self-report of taking anti-anxiety medications, and if participants had identical ip addresses 
(i.e., three or more times – see validity check section below for more information). Participants 
were compensated after completing each phase of the study.  
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This study adhered to the guidelines presented by the American Psychological 
Association for treatment of human research participants. In order to participate, subjects agreed 
to an informed consent form that was approved by the West Virginia University Institutional 
Review Board, protocol #1801957814.  
Video Stimuli 
 In a prior study on treatment of high dental care-related fear and anxiety, as well as 
phobia (McNeil, 2019), 10 publicly-available video clips were identified from YouTubeTM. They 
were selected on the basis of being sequential, from low intensity (e.g., entering a dental office) 
to high intensity (e.g., highly magnified tooth crown preparation and placement). Subjective 
Units of Distress Scale (SUDS; Wolpe, 1973) ratings (i.e., 0-100) were obtained from 29 patients 
who participated in systematic desensitization treatment using an Ipad to deliver the stimuli in a 
dental operatory. From these 10 videos, two were selected (i.e., video 1 and video 5). Refer to 
Appendix A for content of the 10 videos. The videos were selected based on similar length (i.e., 
120 seconds) and self-reported ratings of anxiety experienced when viewing the videos.  
In the prior study (McNeil, 2019), participants were allowed to watch each of the 10 
videos up to three times and provided SUDS ratings (i.e., highest anxiety experienced during the 
video) after watching the video. Mean SUDS ratings across each of the video trials were 
calculated to represent anxiety experienced during the 10 videos. Refer to Table 1 for mean 
anxiety ratings for the 10 videos. Based on the ratings, video 1 (i.e., low intensity) and video 5 
(i.e., high intensity) were selected. A paired samples t-test demonstrated that the high intensity 
video (M = 71.1, SD = 19.7) was rated as significantly higher than the low intensity video (M = 
43.3, SD = 22.1) in terms of self-reported anxiety, t(28) = 7.86, p < .001. 
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There were 30-second trailers created from the two videos and shown to the participants 
as an example for the different video intensities (e.g., low and high). The low intensity exposure 
video depicted a patient walking into a dental clinic (i.e., video 1 in Appendix A), having a short 
conversation with the dental hygienist, and receiving an examination and prophylaxis by a dental 
hygienist. The high intensity exposure video included a patient lying supine in a dental chair 
receiving injections (i.e., video 5 in Appendix A). 
Descriptions of Treatment Options  
 Definitions from the APA Dictionary of Psychology (American Psychological 
Association, 2015) were identified and the different treatment descriptions were presented to 
participants who rated preference, expected efficacy, and willingness to engage in the treatment. 
Refer to Appendix A.   
Self-Report Measures   
 Demographic and general dental information questionnaire. The questionnaire 
consists of 24-items asking about the participants’ age, sex, race/ethnicity, and general dental 
information, as well as content related to a larger study. Refer to Appendix C for specific 
demographic questions.  
Dental Fear Survey (DFS; Kleinknecht, Klepac, & Alexander, 1973). The DFS has 20 
self-report items rated on a 5-point Likert-type scale and has a total score ranging from 20 to 
100, with higher scores being indicative of increased anxiety and fear related to dental care 
(Kleinknecht et al., 1973). Refer to Appendix D. The measure assesses responses (i.e., 
physiological and behavioral) to specific dental situation and circumstances and reflects general 
dental care-related anxiety/fear. The DFS consists of three subscales: Dental avoidance and 
anxiety, Fear of dental stimuli/procedures, and Arousal associated with dental treatment. The 
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DFS also has a single omnibus item, which was used in the screening phase as a qualification to 
participate in the study (i.e., score of 4+ out of 5). The single item has demonstrated high 
correlation with the DFS total score (McGlynn, McNeil, Gallagher, & Vrana, 1987). The DFS 
has low demand on the participant (e.g., time and cognitive requirements), and is widely used in 
behavioral dentistry research. The DFS has demonstrated good reliability (test-retest r = .88) and 
validity (α’s ≥ .75; Heaton, Carlson, Smith, Baer, & De Leeuw, 2007; McGlynn et al., 1987).    
Preference, treatment effectiveness, and willingness to engage in treatment. In order 
to assess preference for types of treatments (i.e., exposure, relaxation, systematic desensitization, 
and flooding), a single-item question was used rated on a 5-point Likert-type scale, which is 
based on typical approach used for studies included in a meta-analysis examining treatment 
preferences (Lindhiem, Bennett, Trentacosta, & McLear, 2014). Refer to Appendix E. Also in 
order to assess preference for types of treatments, participants were asked to rank order 
treatments from most preferred (i.e., 1) to least preferred (i.e., 6), which included common 
approaches for managing phobia (i.e., pharmacological, relaxation, nitrous oxide, systematic 
desensitization, exposure, and flooding). Refer to Appendix F.  
In order to assess preference for exposure stimuli presentation, participants rated 
preference for low intensity stimuli and high intensity stimuli with a single-item question rated 
on a 5-point Likert-type scale. Refer to Appendix E. Also, participants were asked to rank order 
preference for how stimuli should be presented sequentially to treat their dental fear. Refer to 
Appendix G. Similarly in regard to the low intensity and high intensity exposure stimuli, 
treatment effectiveness and willingness to engage in treatment were assessed in the same manner 
as the first preference question (i.e., 5-point scale). Refer to Appendices H and I.  
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 Validity checks. In order to ensure accurate responding in the study and that participants 
watched the exposure video(s), participants answered five validity checks throughout their 
participation in the study (i.e., two in the screening phase and three in the preference phase). 
Refer to Appendix J. Participants who answered both validity check questions correctly in the 
screening phase were included in the screening analyses. Also, participants who answered two or 
more of the three validity check questions correctly in the preference phase were included in the 
analyses. Finally, participants with three or more identical ip addresses were dropped from the 
analysis to prevent the possibility of duplicate responses from one household. Two identical ip 
address were allowed because it was thought reasonable that two people in the same household 
may both be MTurk workers.  
Behavioral Preference Measure 
 The two 30-second trailers (i.e., low intensity and high intensity exposure videos) were 
presented to the participants in a counterbalanced order. Then participants had the opportunity to 
choose to watch the low intensity video, the high intensity video, a black screen (e.g., 
avoidance), or the combination of the three choices a total number of three times. Behavioral 
preference for treatment was calculated by number of times each of the options was viewed.  
Procedure 
Screening Phase  
Participants were invited via MTurk to complete the screening phase, which consisted of 
the demographic questionnaire, DFS, and two validity questions, as well as two other 
instruments not related to the current study. If the participant reported high levels of dental care-
related fear (i.e., 4+ on the single DFS item), then they were invited to participate in the 
preference phase of the study. All participants were provided 25¢ after completing the screening 
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phase. Those who did not qualify for the preference phase were thanked, and those who did 
qualify were invited to participate in the preference phase. 
Preference Phase  
 Participants were provided a series of treatment options with definitions (i.e., systematic 
desensitization, exposure, flooding, and relaxation), and then asked to rank order the types of 
treatments based on preference. After ranking the various types of treatments, participants 
viewed two 30-second trailer videos (i.e., low intensity and high intensity). Order of video 
intensity was randomly assigned. After viewing one of the trailers, participants rated level of 
preference, perceived efficacy, and their own willingness to engage in that method of exposure 
therapy (i.e., low intensity or high intensity). After answering the questions, participants watched 
the second trailer (i.e., high intensity or low intensity), and rated level of preference, perceived 
efficacy, and their own willingness to engage in the method. Then, participants were offered 
their first choice in which video to watch, the 120-second low intensity video, the 120-second 
high intensity video, or the120-second black screen video. After watching their first choice of 
video, participants were offered again the choice of video to watch next (i.e., 120-second low 
intensity video, 120-second high intensity video, or a 120-second black screen). Finally, 
participants were again offered the choice of video to watch a third time. After watching the 
video(s) three times, participants’ rank ordered their preference for the presentation of exposure 
stimuli. Participants were asked to answer a validity check question after watching each video. 
Upon completion of the preference phase, participants were awarded an additional $1.00.  
Study Analyses 
The first hypothesis was assessed by utilizing a repeated measures ANOVA to examine 
preferences for different types of treatment for dental fear/anxiety. Furthermore, the rank order 
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and percentages of the various types of treatment approaches were examined via Friedman tests, 
and planned post-hoc contrasts were examined with Wilcoxon signed-rank tests.  
The second hypothesis was assessed by utilizing a repeated measures ANOVA to 
examine preferences for various methods for presenting exposure stimuli. Rank order and 
percentages for exposure stimuli presentation were also examined via Friedman tests, and 
planned post-hoc contrasts were examined with Wilcoxon signed-rank tests. Finally, a Latent 
Class Analysis was conducted to assess how different groups of participants emerged based on 
which videos were watched over the three trials.  
Paired sample t-tests were used to assess the third hypothesis in regard to preference, 
perceived effectiveness, and willingness to engage in the two methods for delivering exposure 
therapy (i.e., low versus high intensity).   
Results 
A total of 900 participants were included in the analyses for the screening phase of the 
study, and of those participants, 235 were included in the analyses for preference phase of the 
study. Refer to figure 1 for a flowchart of participant inclusion/exclusion. Table 2 includes 
demographic characteristics and tests for possible group differences between those in the 
screening and those in the preference phase.   
 Hypothesis 1 
 To assess preferences for various specific phobia treatments, a repeated measure 
ANOVA was conducted. Results indicated a significant difference of preference rating (i.e., 0-4 
scale) among the four possible treatments, F(2.83, 571.776) = 54.34, p < .001, partial eta2 = .212. 
Relaxation (M = 2.0 SD = 1.1) was rated as more preferred than Systematic Desensitization (M = 
1.8 SD = 1.2), Exposure (M = 1.6 SD = 1.2), and Flooding (M = .9 SD = 1.2). Systematic 
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Desensitization and Exposure did not differ, but both were rated as more preferred than flooding. 
Refer to Figure 2.  
Also, a Friedman test was used to examine ranked preferences (i.e., 1 most preferred to 6 
least preferred) for various types of specific phobia treatment. There was a significant difference 
in participant preference rankings, χ2(5) = 283.06, p < 0.001. Planned post-hoc contrasts via 
Wilcoxon signed-rank test comparing systematic desensitization and the other options were 
conducted with a Bonferroni correction (i.e., p < 0.01). Systematic Desensitization was ranked as 
less preferred than Relaxation, more preferred than Exposure or Flooding, and did not differ 
from Pharmacological or Nitrous Oxide. Refer to Figure 3.  
A post hoc test was conducted to examine participants’ top preferred treatment option 
(i.e., relaxation) compared to the other treatments with a Wilcoxon signed-rank test with a 
Bonferroni correction (i.e., p < 0.01). Relaxation was ranked as more preferred than Systematic 
Desensitization, Exposure, and Flooding.  
Hypothesis 2 
 A Friedman test was utilized to assess ranked preference for various exposure treatment 
methods. There was a significant difference in participant preference ratings for various exposure 
methods, χ2(4) = 239.35, p < 0.001. Planned post hoc contrasts via a Wilcoxon signed-rank test 
comparing a gradual accelerating approach and the other options was conducted with a 
Bonferroni correction (i.e., p < 0.0125). The gradual accelerating approach (i.e., Low to High) 
was ranked as less preferred than the low-intensity approach, and ranked as more preferred than 
the random approach, the gradual decelerating approach (i.e., high to low intensity), and the 
high-intensity approach. Refer to Figure 4.  
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 A post hoc test was conducted to examine participants top preferred exposure method 
(i.e., Low intensity) compared to the other methods with a Wilcoxon signed-rank test with a 
Bonferroni correction (i.e., p < 0. 0125). The low-intensity approached was ranked as more 
preferred than the gradual accelerating approach, random approach, gradual decelerating 
approach (i.e., high to low intensity), and high-intensity approach.  
Hypothesis 3a 
A paired samples t-test was conducted to examine participant ratings of perceived 
preference for the low intensity versus the high intensity video content. Participants self-reported 
higher preference for the low intensity video content (M = 2.5, SD = 1.2) compared to the high 
intensity content video (M = 1.1, SD = 1.3), t(234) = 12.98, p < .001, d = 1.12.   
In order to examine level of willingness to engage in various exposure treatments (e.g., 
low intensity versus high intensity), a repeated measures ANOVA was conducted based on total 
number of times the different video contents were watched (i.e., 0-3 times). Analysis indicated a 
significant main effect for total videos watched, F(1.873, 438.392) = 20.34, p < .001, partial eta2 
= .079, such that low intensity (M = 1.3, SD = 1.0) and the black screen (M = 1.1, SD = 1.1) were 
watched more than the high intensity (M = .6, SD = .9). Viewing of the black screen and low 
intensity videos did not differ.  
Total number of times each video type was watched (i.e., 0-3) was used to examine 
participant preference for each video type (i.e., low intensity preference, high intensity 
preference, avoidance preference, and no preference). A low intensity preference would 
correspond to participants who watched the low intensity video two or more times, a high 
intensity preferences are those who watched the high intensity video two or more times, an 
avoidance preference are individuals who watched the black screen video two or more times, and 
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no preference includes participants who watched each video type only once. A total of 93 
(39.6%) participants demonstrated a low intensity preference, 35 (14.9%) showed a high 
intensity preference, 77 (32.8%) demonstrated an avoidance preference, and 30 (12.8%) 
exhibited no video preference.  
 A Latent Class Analysis was utilized to assess for differential patterns of watching the 
exposure videos. The number of classes extracted were based on various fit indices across 
various models with an iterative process (e.g., akaike information criterion, bayesian information 
criterion, entropy, and bootstrapped likelihood ratio test; Jung & Wickrama, 2008; Wang & 
Wang, 2012). Results suggest a two-class solution with a “Prefer Low Activation” group 
(69.5%) and an “Avoidant” group (30.5%). Refer to Table 3 for fit indices and to Figure 5 for 
class probabilities with each video choice across the three trials (e.g., the likelihood that a 
participant in one of the determined groups would select the low intensity, high intensity, or 
black screen at each trial). Thus, class probability ranges from 0% (i.e., no chance of selecting 
the video type) to 100% (i.e., participant will definitely choose the video type). The Prefer Low 
Activation group had a probability of 60% for choosing the low intensity video for the first trial, 
a 57% for the second trial, and 47% chance of choosing it for the third trial. For this group, 
participants’ probability of avoiding (i.e., choosing the black screen) increased with each trial, 
7%, 15%, and 29%, respectively. Thus, participants in this group were more likely at each 
subsequent trial to avoid rather than watch on of the exposure videos. Finally, the Avoidant 
group consistently had a greater probability of avoiding the videos over the three trials with 74% 
in trial 1, 88% in trial 2, and 86% in trial 3. Furthermore, the probability of selecting the high 
intensity video was the least likely in this group.  
Hypothesis 3b 
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 To assess participant ratings of perceived effectiveness for the low intensity versus the 
high intensity exposure treatment approach, a paired samples t-test was utilized. Analysis 
indicated that participants rated the low intensity exposure (M = 1.8, SD = 1.4) as likely to be 
more effective than the high intensity exposure (M = 1.2, SD = 1.3), t(234) = 6.27, p < .001, d = 
0.44.  
Hypothesis 3c 
 To assess participant willingness to engage in low intensity treatment versus high 
intensity treatment, a paired samples t-test was utilized. Analysis indicated that participants rated 
more willingness to engage in the low intensity exposure (M = 2.5, SD = 1.2) than the high 
intensity exposure (M = 1.3, SD = 1.4), t(234) = 11.44, p < .001, d = 0.92.  
Discussion  
 A goal of this study was to examine patient preferences for available treatments for 
specific phobia, with dental care-related fear, anxiety, and phobia, as an exemplar. Previous 
studies have compared patient preferences for pharmacological versus psychological treatment 
(McHugh & Whitton, 2013) or CBT versus other psychotherapeutic treatments (Frövenholt et 
al., 2007). To date, however, no one has assessed patient treatment preference with an extensive 
list of treatments (e.g., medications, exposure, relaxation, nitrous oxide, flooding). Overall, 
participants appear to prefer the least intensive approach (e.g., relaxation or a low intensity 
exposure). The most illuminating results of the current study may be that participants rated 
relaxation as a more preferred treatment than other options, including medications and nitrous 
oxide. Although participants rating relaxation as the most preferred option for their dental 
fear/anxiety was surprising, evidence supports the approach specifically with dental phobia 
(Armfield & Heaton, 2013). Relaxation can help with more than the fear and anxiety experienced 
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and may decrease overall pain experienced during a dental visit (Armfield & Heaton, 2013). 
Furthermore, the results are consistent with patient preference for CBT treatments compared to 
pharmacological treatment for other specific phobias and anxiety disorders more generally 
(McHugh & Whitton, 2013). The findings suggest that participants may want help reducing 
stress experienced at a dental visit via behavioral training rather than using medications/sedatives 
or other psychological approaches (e.g., exposure).  
 Another goal of the current study was to examine patient preference for specific 
components involved in exposure therapy (e.g., order of stimuli presentation). Some key factors 
that impact exposure effectiveness are learning new information that violates a previously held 
fear-structure and increased arousal during the exposure (Craske et al., 2014; Culver et al., 2012; 
Foa & Kozak, 1986). Therefore, it was hypothesized that participants would rate a gradual 
accelerating intensity as most preferred; however, participants consistently demonstrated a 
preference for the low intensity stimuli, which in retrospect may not be surprising given the 
nature of exposure therapy (e.g., confronting a fear) and related high levels of dropout and low 
levels of adherence (Choy et al., 2007; Taylor et al., 2012). The self-reported preference for low 
intensity versus high intensity exposure stimuli was further supported by actual behaviors. 
Participants were more likely to watch the low intensity video or avoid the videos completely 
than watch the high intensity video across the three trials. The findings suggest when presented 
the opportunity to choose between low intensity, high intensity, or avoid altogether, participants 
were more likely to choose the low intensity stimuli or avoid the stimuli. 
The Latent Class Analysis supports these findings as well and suggests that there were 
two distinct groups. Given the previous results of a preference for low intensity or avoidance, it 
is not surprising that the most consistent group (e.g., watched the same exposure stimuli intensity 
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over the three trials) was those who avoided the videos completely (i.e., Avoidant group). The 
second group (i.e., a Low to Avoidant group) again demonstrates a preference for low intensity 
stimuli or avoidance, and these individuals appear to be willing to engage in this type of 
treatment, at least at low levels. It has been shown that a low intensity exposure for dental fear, 
anxiety, and phobia over a two-week period was effective in decreasing self-reported anxiety 
during a behavioral avoidance task (Arias & McNeil, 2019). Results suggest that with each trial, 
however, the probability of participants avoiding the videos increased, which is inconsistent with 
Simpson et al. (2011). The difference could be due to the participants in the present study 
watched the same low intensity content rather than systematically increasing stimuli intensity as 
in Simpson et al.'s (2011) study. The variety of low intensity stimuli, therefore, may have 
improved treatment adherence rates more than just the low intensity stimuli. Based on Arias and 
McNeil (2019), however, watching a low intensity exposure may need to persist across several 
weeks rather than one session. Furthermore, participants on average were only watching the low 
intensity exposure once per day (Arias & McNeil, 2019), which is consistent with the behavioral 
pattern of the present participants (i.e., increasing likelihood of choosing the avoid option as the 
participants progressed through the three trials).  
 Finally, the current study assessed patient perceptions about exposure therapy and the 
various methods to present stimuli. Similar to the previous findings, participants self-reported the 
low intensity exposure as more preferred than the high intensity exposure. Inconsistent with the 
proposed hypothesis, however, participants rated the low intensity exposure as likely to be more 
effective than the high intensity exposure. The differences, however, may not be clinically 
significant, based on the small effect sizes. Nonetheless, participants’ perception for 
effectiveness of the two treatment approaches were rated as moderate, which is consistent with 
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previous findings (Becker, Darius, & Schaumberg, 2007). Lastly, participants reported a greater 
willingness to watch the low intensity exposure videos as compared to watching the high 
intensity videos as a method of exposure treatment. Previous research suggests that patients with 
high levels of dental care-related fear/anxiety are quite adherent when the stimuli presented was 
considered by the patients as low intensity (Arias & McNeil, 2019). The self-reported 
willingness to engage in low intensity exposure was further supported by the results of the Latent 
Class Analysis; where, most participants (regardless of class) avoided watching the high 
intensity videos.  
 The results of this study highlight important factors that can be considered to improve 
efficacy of specific phobia treatment. In particular, clinicians should consider patient preferences 
for treatment because they are inherently tied to therapeutic outcomes and patient adherence. A 
significant finding was participant preferences for relaxation as a treatment option, which could 
easily be integrated into dental practices. Dental care providers can equip and train their patients 
to utilize relaxation approaches within the office, which can decrease patient and provider 
burden. Furthermore, dental care providers can offer relaxation as a treatment for those with high 
levels of dental fear/anxiety with other commonly provided options (e.g., sedation) and allow the 
patient to choose based on their preference. Another important finding of this study is that it may 
behoove clinicians to consider patient preference when delivering exposure therapy, such as 
offering a low intensity approach rather than the typical gradual accelerating approach. Also, 
based on previous findings (i.e., Arias & McNeil, 2019) and the results of this study, it may add 
to the theoretical approach of exposure therapy, such that a low intensity approach may be 
effective and accepted by individuals with dental phobia. Moreover, this study highlights on 
perhaps adopting a low intensity approach at first to increase buy-in and adherence before 
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moving to higher intensity exposure. Overall, it is important to consider patient preferences in all 
areas of treatment, which can improve treatment outcomes and adherence rates.  
This study is not without limitations. Despite the positive aspects of MTurk as a source to 
collect participant responses, MTurk samples, compared to national samples, may be less 
representative of USA demographics (Berinsky, Huber, & Lenz, 2012). Overall, MTurk samples 
appear to have higher educated participants (e.g., college degree), more likely to identify as 
female, and are more likely to report living in urban areas when compared to national norms 
(Huff & Tingley, 2015). A potential problem with MTurk samples is a higher social desirability 
bias effect and possible lower engagement compared to research conducted in-person (Peer, 
Vosgerau, & Acquisti, 2014). Despite the potential limitations of MTurk, it was chosen to recruit 
participants because of the need for a large, generalizable population.  
The preference phase of the study had more women enrolled than men, which is a 
limitation. However, the rates of men enrolled in the screening phase was approximately even 
with women. The difference in men who qualified for the preference phase may not be all that 
surprising. It has been shown that men often report lower anxiety levels, whereas women report 
higher ones (Craske, 2003). Due to this fact, it may have been better to lower the inclusion 
criteria of reporting a 4+ on the DFS item 20 for men to 3+ to have a similar distribution in the 
preference phase. Future studies can examine how men who rate a 3 on the DFS item 20 differ 
from those who rate a 4 on the item.   
Another potential limitation of this study is that there is no way of knowing if the 
participants watched the videos attentively, or at all. Steps were taken, however, to ensure the 
participants watched the videos in their entirety and the study’s design even provided an option 
to avoid (e.g., black screen). Future research can examine if videos watched in a clinic setting 
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versus online make a difference in self-reported preference for exposure methods. Also, 
participant ratings of perceived efficacy for the exposure methods (i.e., low intensity and high 
intensity) may have been confounded by their self-reported preference, which may explain why 
participants rated the low intensity approach has more effective than the high intensity approach. 
Thus, future studies can examine in greater detail why individuals prefer one method over the 
other. Lastly, the study did not provide exposure treatment to the participants, and so the relation 
of preferences to efficacy is unknown. Future research should investigate whether educating 
patients about the efficacy and speed of impact affects treatment preferences.  
Taking into consideration patient preferences for treatment options and methods provides 
a host of advantages. Ultimately, the goal for treatments is to be effective, but it is critical that 
they be accepted and utilized by patients (McNeil, 2011). A gold standard treatment is useless if 
patients are not willing to utilize it. Furthermore, patient preference for various treatments and 
perceived effectiveness of the treatments can impact the level of commitment to the regimen, 
which can impact treatment outcomes. This study directly assessed preferences for treatment of 
specific phobia, and various delivery methods. Results demonstrated that low intensity exposure 
was preferred by those with high levels of dental care-related fear and anxiety, was seen as 
effective, and was associated with a willingness to engage in the treatment. Furthermore, 
participants rated relaxation as the most preferred type of treatment, which could have a direct 
impact on dental care-related services and should influence the current state of oral  
healthcare.  
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 Figure 1. Participant Flow for Inclusion in the Study 
 
Assessed for eligibility (n = 1,065) 
Participants who did not qualify for 
preference phase of the study 
(n = 696) 
Participants who qualified for 
preference phase of the study 
(n = 369)  
Participants after removing 
incomplete data  
(n = 658)  
Participants after removing 
incomplete data 
(n = 265)  
Participants after removing multiple 
responses (i.e., 3 or more identical IP 
addresses; n = 646)    
Participants after removing multiple 
responses (i.e., 3 or more identical IP 
addresses; n = 254)  
Participants agreeing to 
participant in preference phase 
(n = 245)  
Participants declining to 
participant in preference phase 
(n = 9)  
Participants after removing those 
currently receiving treatment  
(n = 235)   
Participants after removing those 
who failed validation questions 
(n = 668) 
Participants after removing those 
who failed validation questions 
 (n = 338)  
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Figure 2. Participant Preference for Various Types of Treatments. Columns that do not share a 
common superscript differ at p < .05.  
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Figure 3. Participant ranked preference for types of treatments. Planned post-hoc contrasts via Wilcoxon 
signed-rank test comparing systematic desensitization and the other options were conducted with a 
Bonferroni correction (i.e., p < 0.01). Columns that do not share a common superscript with Systematic 
Desensitization differ at p < .01. Lower ranks indicate a higher preference for that treatment; for example, 
a score of one would indicate a first choice option and a score of 6 would indicate last choice option.  
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Figure 4. Graph of Participant Ranked Preference for Presentation of Exposure Stimuli. Planned post hoc 
contrasts via a Wilcoxon signed-rank test comparing gradual accelerating approach (i.e., Low then High 
Intensity) and the other options was conducted with a Bonferroni correction (i.e., p < 0.0125). Columns 
that do not share a common superscript with Low then High Intensity differ at p < .0125.  Lower ranks 
indicate a higher preference for that treatment; for example, a score of one would indicate a first choice 
option and a score of 6 would indicate last choice option. 
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Figure 5. Latent Class Analysis for Videos Watched over the Three Trials. The y-axis is the probability (e.g., likelihood) of selecting the different 
video types (i.e., black screen, how intensity, or high intensity) based on which group participants were identified. Avoid1, Avoid2, and Avoid3 is 
the black screen option for the three trials. The Low1, Low2, and Low3 is the low intensity option for the three trials. The High1, High2, and 
High3 is the high intensity option for the three trials.  
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Table 1  
Anxiety Ratings for Exposure Videos Considered for Inclusion in Present Study 
 
Mean (SD) Video Length (Sec) 
Number of 
Participants Who 
Watched the Video 
in the Prior Study 
Video Content 
*Video 1 43.3 (22.1) 120 29 
Patient walking into a dental clinic. Then the patient had a short 
conversation with the dental hygienist. Finally, the dental hygienist 
performed an examination and prophylaxis. 
Video 2 37.8 (23.0) 29 29 Patient is lying supine in a dental chair being  examined by a dentist. 
Video 3 47.7 (24.6) 28 29 Patient receiving a teeth cleaning. 
Video 4 54.2 (18.6) 120 29 Dentist performing a scaling on a patient’s teeth. 
*Video 5 71.1 (19.7) 120 29 Patient lying supine in a dental chair receiving injections. 
Video 6 36.8 (19.7) 44 28 View of an open mouth while a root planning is being performed. 
Video 7 61.2 (19.8) 120 28 Dentist drilling into a tooth of a patient. 
Video 8 63.2 (19.4) 120 24 A close-up view of a tooth being drilled. 
Video 9 61.4 (19.0) 120 14 Patient having a tooth removed. 
Video 10 38.5 (16.4) 120 8 Patient receiving a crown on a tooth. 
 
Note. *Videos selected for the current study. Not all participants viewed all 10 videos. SD = standard deviation.    
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Table 2  
Sample Demographic Characteristics and Tests for Possible Differences 
 Participants Mean (SD)  
 Screen Preference Statistic p-value Combined 
Age 38.4 (12.5) 39.5 (12) t(877) = -1.2 p = .241 38.7 (12.3) 
Education 15.5 (2.3) 15.2 (2.1) t(877) = 1.9 p = .053 15.5 (2.2) 
 
 N (%)   N (%) 
Sex   c2 = 27.2 p < .001  
Female 309 (47.8%) 159 (67.7%)   468 (53.1%) 
Male 337 (52.2%) 76 (32.3%)   413 (46.9%) 
Statistic c2 = 1.2 c2 = 29.3   c2 = 3.4 
p-value p = .27 p < .001   p = .064 
      
 N (%)  N (%) 
Race/Ethnicity*      
White 513 (79.4%) 184 (78.3%) c2 = 1.2  p = .72 697 (79.1%) 
Black/African 
American 63 (9.7%) 47 (16.8%) c
2 = 1.5   p = .22 87 (9.9%) 
Latinx/Hispanic 36 (5.5%) 14 (5%) c2 = 0.6 p = .44 46 (5.2%) 
Asian 51 (7.8%) 22 (7.9%)   c2 = .1 p = .75 68 (7.7%) 
Native American 12 (1.8%) 1 (0.4%) c2 = 4.4 p = .035 12 (1.4%) 
      
 Mean (SD)  Mean (SD) 
DFS Total 40.2 (15.8) 75.8 (15.6) t(447.52) = -31.4 p < .001 49.7 (22.1) 
DFS Item 20 2.0 (0.8) 4.4 (0.5) t(670.53) = -52.7 p < .001 2.7 (1.3) 
 
Note. *Percentages equal more than 100% due to participants choosing more than one 
race/ethnicity. SD = standard deviation. N = number. Chi-Square analyses were conducted for 
sex differences among and between both the screening and preference phase participants. Chi-
Square analyses were conducted for race/ethnicity differences between the screening and 
preference phase participants.   
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Table 3  
Fit Indices for Latent Class Analysis  
 AIC BIC ABIC Entropy LMR LR  ALMR LR  BLRT  
1 class 1855.715 1877.837 1858.809 - - - - 
2 class 1729.239 1777.169 1735.943 0.765 p < .001 p < .001 p < .001 
3 class 1677.322 1751.062 1687.636 0.838 p = .62 p = .63 p < .001 
 
Note. AIC = Akaike information criterion. BIC = Bayesian information criterion. ABIC = adjusted Bayesian information criterion. LMR LR = Lo-
Mendell-Rubin likelihood ratio test. ALMR LR = adjusted Lo-Mendell-Rubin likelihood ratio test. BLRT = bootstrapped likelihood ratio test.  
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Appendix A 
Exposure Videos Considered for Inclusion in Present Study 
1. Patient walking into a dental clinic. Then the patient had a short conversation with the 
dental hygienist. Finally, the dental hygienist performed an examination and prophylaxis. 
2. Patient is lying supine in a dental chair being examined by a dentist. 
3. Patient receiving a teeth cleaning.  
4. Dentist performing a scaling on a patient’s teeth.  
5. Patient lying supine in a dental chair receiving injections. 
6. View of an open mouth while a root planning is being performed.  
7. Dentist drilling into a tooth of a patient.  
8. A close-up view of a tooth being drilled.  
9. Patient having a tooth removed.  
10. Patient receiving a crown on a tooth.  
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Appendix B 
Descriptions of Treatment Options from the APA Dictionary of Psychology  
(American Psychological Association, 2015) 
“Systematic Desensitization: a form of behavior therapy in which counterconditioning is used 
to reduce anxiety associated with a particular stimulus. It involves the following stages: (a) The 
client is trained in deep-muscle relaxation; (b) various anxiety-provoking situations related to a 
particular problem, such as fear of death or a specific phobia, are listed in order from weakest to 
strongest; and (c) each of these situations is presented in imagination or in reality, beginning with 
the weakest, while the client practices muscle relaxation. Since the muscle relaxation is 
incompatible with the anxiety, the client gradually responds less to the anxiety-provoking 
situations.” 
 
“Relaxation: a technique in which the individual is trained to relax the entire body by becoming 
aware of tensions in various muscle groups and then relaxing one muscle group at a time. In 
some cases, the individual consciously tenses specific muscles or muscle groups and then 
releases tension to achieve relaxation throughout the body. Relaxation technique [is] any 
therapeutic technique to induce relaxation and reduce stress. Also called relaxation training. 
Relaxation therapy [is the] use of muscle-relaxation techniques to aid in the treatment of 
emotional tension. Also called therapeutic relaxation.”  
 
“Exposure therapy: a form of behavior therapy that is effective in treating anxiety disorders. It 
involves systematic and repeated confrontation with a feared stimulus, either in vivo (live) or in 
the imagination. It works by (a) implosive therapy, habituation, in which repeated exposure 
reduces anxiety over time by a process of extinction; (b) disconfirming fearful predictions; and 
(c) increasing feelings of self-efficacy and mastery. In vivo exposure [is] a type of exposure 
therapy, generally used for treating individuals with phobias, obsessive compulsive disorder, and 
other anxiety disorders, in which the client directly experiences anxiety-provoking situations or 
stimuli in real-world conditions. For example, a client who fears flying could be accompanied by 
a therapist to the airport to simulate boarding a plane while practicing anxiety-decreasing 
techniques, such as deep breathing. Imaginal exposure [is] a type of exposure therapy used for 
treating individuals with anxiety disorders (e.g., phobias, obsessive-compulsive disorder, 
posttraumatic stress disorder). Vivid imagery evoked through speech is used by the therapist to 
expose the client mentally to an anxiety evoking stimulus.”  
 
“Flooding: a technique in behavior therapy in which the individual is exposed directly to a 
maximum-intensity anxiety-producing situation or stimulus, either described or real, without any 
attempt made to lessen or avoid anxiety or fear during the exposure. An individual with 
claustrophobia, for example, might be asked to spend extended periods of time in a small room. 
Flooding techniques aim to diminish or extinguish the undesired response to a feared situation or 
stimulus and are used primarily in the treatment of individuals with phobias and similar 
disorders.” 
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Appendix C 
Demographic and General Dental Information Questionnaire 
 
1. What is your sex? 
a. Male  
b. Female 
 
2. What is your age?    
a. ________ years 
 
3. What is your race/ethnicity? Select all that Apply: 
a. White/Caucasian  
b. Black/African American 
c. Hispanic 
d. Asian 
e. Indian or Alaskan Native 
f. Other: ______________ 
 
4. What is your marital status?   
a. Single  
b. Separated 
c. Married 
d. Divorced 
e. Live-in partner 
f. Widowed 
 
5. Number of years of education? (For example, High School Diploma = 12 years, College 
Degree = 16 years) 
a. ______________ years 
 
6. What is your job or occupation?  
a. _________________________________ 
 
7. What is your current job or occupation status?   
a. Working full time  
b. Working part time 
c. Looking for work – unemployed 
d. Retired 
e. Disabled – unable to work 
 
8. How do you get to dental appointments?   
a. Have a car/truck/vehicle that I primarily or solely use  
b. Have a car/truck/vehicle that I share with a spouse/partner 
c. Borrow a car/truck/vehicle 
d. Have a family member bring me 
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e. Have a friend bring me 
f. Have a social services agency bring me 
g. Other: ____________________________ 
 
9. For the vehicle that gets you to dental appointments, how reliably does it run?     
Very Unreliable        Very Reliable 
0   1   2   3    4 
         
10. What factors make it difficult for you to schedule or attend dental care appointments? 
(circle or list all that apply)   
a. Hard to get away from work 
b. Transportation hard to arrange 
c. Not covered by insurance  
d. Other: ________________________ 
 
11. How long since you last saw a dentist?    
a. Within the last 6 months  
b. 6 months – 1 year 
c. 1 – 2 years 
d. 2 – 5 years 
e. 5 – 10 years 
f. More than 10 years 
g. Never saw a dentist 
 
12. When you go to the dentist, what typically gets you to go?  
a. Regular cleaning and exam 
b. Pain 
c. Seeing a cavity or another problem in my mouth 
d. Other: _____________________________ 
 
13. Do you presently have any dental pain?    
No Pain          Severe Pain 
0  1  2  3  4    
 
14. Have you had any prior psychological treatment?   
a. Yes  
b. No 
 
15. If you received previous psychological treatment, what were you treated for? (if this does 
not apply to you please respond with N/A)  
a. _________________________________________________ 
b. When did you start treatment? ________________________ 
c. When did you end treatment?  ________________________ 
d. Are you currently in treatment? _______________________ 
 
16. Do you have any extreme fears or phobia? If so, please list. 
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a. Yes _____________________________________________ 
b. No 
 
17. Are you currently taking any medications for mental health issues? If so, please list. 
a. Yes _____________________________________ 
b. No 
 
18. Have you ever taken any medications for mental health issues? If so, please list.  
a. Yes _____________________________________ 
b. No 
 
19. Have you ever received treatment for dental fear? If so, please list treatment(s).  
a. Yes ______________________________________ 
b. No 
 
20. When did you start treatment for your dental fear?  
a. __________________________________________ 
b. Does not apply  
 
21. When did you end treatment for your dental fear?  
a. __________________________________________ 
b. Does not apply  
 
22. Are you currently in treatment for your dental fear? 
a. Yes 
b. No 
c. Does not apply  
 
23. How often do you take medications for fear/anxiety when attending a dental visit? 
a. Every time  
b. Almost every time  
c. More than half of the time 
d. Less than half of the time 
e. Rarely 
f. Never 
g. I have never gone to the dentist  
 
24. How often do you use nitrous oxide for fear/anxiety when attending a dental visit? 
a. Every time  
b. Almost every time  
c. More than half of the time 
d. Less than half of the time 
e. Rarely 
f. Never 
g. I have never gone to the dentist        
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Appendix D 
Dental Fear Survey  
INSTRUCTIONS: The items in this questionnaire refer to various situations, feelings, and 
reactions related to dental work.  Please rate your feeling or reaction on these items by using the 
following scales. Fill in the appropriate circle which most closely corresponds to your reaction. 
 
 Never Once or 
twice 
A few 
times 
Often Nearly 
every time 
1. Has fear of dental work ever caused you 
    to put off making an appointment? 
1 2 3 4 5 
2. Has fear of dental work ever caused you 
__to cancel or not appear for an 
__appointment? 
1 2 3 4 5 
 
When having dental work done: 
 Not At All A little Somewhat Much Very much 
3. My muscles become tense… 1 2 3 4 5 
4. My breathing rate increases… 1 2 3 4 5 
5. I perspire… 1 2 3 4 5 
6. I feel nauseated and sick to my 
    stomach… 
1 2 3 4 5 
7. My heart beats faster… 1 2 3 4 5 
 
Following is a list of things, and situations that many people mention as being somewhat anxiety 
or fear producing.  Please rate how much fear, anxiety, or unpleasantness each of them causes 
you.  (If it helps, try to imagine yourself in each of these situations and describe what your 
common reaction is.) 
 Not At 
All 
A 
little 
Somewhat Much Very 
much 
8. Making an appointment for dentistry. 1 2 3 4 5 
9. Approaching the dentist’s office. 1 2 3 4 5 
10. Sitting in the waiting room. 1 2 3 4 5 
11. Being seated in the dental chair. 1 2 3 4 5 
12. The smell of the dentist’s office. 1 2 3 4 5 
13. Seeing the dentist walk in. 1 2 3 4 5 
14. Seeing the anesthetic needle. 1 2 3 4 5 
15. Feeling the needle injected. 1 2 3 4 5 
16. Seeing the drill. 1 2 3 4 5 
17. Hearing the drill. 1 2 3 4 5 
18. Feeling the vibrations of the drill. 1 2 3 4 5 
19. Having your teeth cleaned. 1 2 3 4 5 
20. All things considered, how fearful are you 
___of having dental work done? 
1 2 3 4 5 
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Appendix E  
Treatment Preference  
What is your level of preference for the proposed treatment that you just read 
about/watched?   
   
Low Preference        High Preference  
0  1  2   3    4   
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Appendix F 
Treatment Preference Ranking  
Please rank the following ways to manage your dental fear/anxiety by your preference:  
a. Medication 
b. Systematic desensitization 
c. Relaxation 
d. Exposure therapy 
e. Flooding 
f. Nitrous Oxide  
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Appendix G 
Stimuli Order Presentation Preference Ranking  
Please rank the following ways you prefer to use the videos that you watch in order to 
treat your dental fear/anxiety:  
a. Low intensity exposure  
b. High intensity exposure  
c. Low intensity then high intensity  
d. High intensity then low intensity  
e. Random order of low and high intensity  
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Appendix H 
Treatment Effectiveness 
1. How effective would you consider the LOW intensity exposure videos would be in 
treating your dental fear/anxiety?   
   
Ineffective         Effective  
0  1  2   3    4   
 
 
2. How effective would you consider the HIGH intensity exposure videos would be in 
treating your dental fear/anxiety?   
   
Ineffective         Effective  
0  1  2   3    4   
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Appendix I 
Willingness to Engage in Treatment 
1. How willing would you be to engage in LOW intensity exposure to treat your dental 
fear/anxiety?   
   
Unwilling          Willing 
0  1  2   3    4   
 
 
2. How effective would you consider the HIGH intensity exposure videos would be in 
treating your dental fear/anxiety?   
   
Unwilling          Willing 
0  1  2   3    4   
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Appendix J 
Validity Check Question 
1. What color are healthy teeth? 
 
a. Red 
b. Green 
c. White 
d. Black 
 
2. Please select the number four for this question 
 
a. 1  
b. 2  
c. 3  
d. 4  
e. 5 
 
3a*. What color outfit was the dental hygienist wearing? 
a. Red  
b. Black 
c. White 
d. Yellow 
e. Green 
 
3b^. Was the patient wearing glasses in the video?  
a. Yes  
b. No 
 
4a*. How many people were present most of the time in the video? 
a. 1 
b. 2 
c. 3 
d. 4 
 
4b^. The patient in the video... 
a. Was clean shaven 
b. Had a mustache 
c. Had a goatee 
d. Had a full beard 
 
5a*. The patient was a  
a. Male  
b. Female 
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5b^. What procedure took place in the video?  
a. Tooth extraction  
b. Shots to numb the mouth 
c. Drilling tooth to fill a cavity  
d. Teeth polishing  
 
 
Note. *represents questions presented after viewing the low intensity video. ^represents 
questions presented after viewing the high intensity video.  
 
